Jonathan Hau

发表

Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNα-driven lupus nephritis.

Adam R. Johnson, Z. Modrušan, J. DeVoss, 2017, JCI insight.

In Vitro and In Vivo Evaluation of Amorphous Solid Dispersions Generated by Different Bench-Scale Processes, Using Griseofulvin as a Model Compound

Y. Ran, J. Lubach, H. Wong, 2013, The AAPS Journal.

Water-soluble prodrugs of an Aurora kinase inhibitor.

Amy D. Fung, R. Mcdowell, J. Jacobs, 2009, Bioorganic & medicinal chemistry letters.

Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton's Tyrosine Kinase Inhibitor in Early Clinical Development.

Adam R. Johnson, BinQing Wei, C. Eigenbrot, 2018, Journal of medicinal chemistry.

Solid-State NMR Investigation of Drug-Excipient Interactions and Phase Behavior in Indomethacin-Eudragit E Amorphous Solid Dispersions

J. Lubach, Jonathan Hau, 2018, Pharmaceutical Research.

Investigation of the rat model for preclinical evaluation of pH-dependent oral absorption in humans.

J. Lubach, H. Wong, Lichuan Liu, 2013, Molecular pharmaceutics.

A rational approach towards development of amorphous solid dispersions: Experimental and computational techniques.

J. Lubach, K. Nagapudi, Paroma Chakravarty, 2017, International journal of pharmaceutics.

Impact of Surfactant Selection and Incorporation on in situ Nanoparticle Formation from Amorphous Solid Dispersions.

A. Estevez, Wei Zhang, K. Nagapudi, 2021, International journal of pharmaceutics.

In Vitro and In Vivo Evaluation of Amorphous Solid Dispersions Generated by Different Bench-Scale Processes, Using Griseofulvin as a Model Compound

Y. Ran, J. Lubach, H. Wong, 2013, The AAPS Journal.